Journal profile
Matrix Science Medica
ISSN 2521-0807 · eISSN 2521-0424 · Zibeline International · Malaysia
Matrix Science Medica: fully open access; no APC; median 52 days to acceptance (24 articles, last 24 months); 20 articles in 2025.
Scope
Aims, scope and focus
Matrix Science Medica is published by Zibeline International. By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and COVID-19 epidemiological studies, together about 19.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Matrix Science Medica (MSM) encourages research that bridges basic medical sciences, translational research, clinical medicine, and public health, with a focus on scientific excellence, innovation, and practical relevance to healthcare professionals, researchers, and policymakers. The scope of the journal includes, but is not limited to, the following areas: Clinical Medicine and Medical Practice Biomedical and Life Sciences Public Health and Preventive Medicine Epidemiology and Disease Control Pharmacology and Pharmaceutical Sciences Medical Biotechnology and Molecular Medicine Genetics and Genomics Infectious Diseases and Microbiology Non-Communicable Diseases Cardiovascular Medicine Endocrinology and Metabolic Disorders Oncology and Cancer Research Neurology and Neurosciences Medical Diagnostics and Therapeutics Healthcare Management and Policy Community and Environmental Health Telemedicine and Digital Health Allied Health Sciences Translational and Experimental Medicine Healthcare Innovation and Emerging Medical Technologies MSM particularly welcomes multidisciplinary studies that integrate scientific discovery with clinical application and healthcare practice. The journal seeks to facilitate collaboration among researchers, clinicians, healthcare professionals, educators, and policymakers while supporting the global dissemination of evidence-based medical research that contributes to the prevention, diagnosis, treatment, and management of human diseases and the improvement of public health worldwide.
From the journal's Aims & Scope
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine7.4%
- SARS-CoV-2 and COVID-19 ResearchMedicine6.6%
- COVID-19 epidemiological studiesMathematics5.7%
- Vestibular and auditory disordersNeuroscience5.7%
- Ear Surgery and Otitis MediaMedicine5.7%
- Medicinal Plant ResearchAgricultural and Biological Sciences5.7%
- Hearing, Cochlea, Tinnitus, GeneticsNeuroscience4.1%
- Physical Activity and HealthMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EBSCO, CNKIPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore (publisher) 2025
- 3.6Publisher website ·
- SJR (publisher) 2025
- 0.39Publisher website ·
- h-index
- 13OpenAlex ·
- i10-index
- 21OpenAlex ·
- 2-year mean citedness
- 0.56OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher)
- 23,304,000Publisher website ·
Articles by year OpenAlex count · 184 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 59 |
| 2025 | 20 | 20 | 65 |
| 2024 | 19 | 19 | 73 |
| 2023 | 24 | 24 | 66 |
| 2022 | 24 | 24 | 62 |
| 2021 | 26 | 26 | 84 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
52 daysMedian, submission to acceptance · P25–P75 33 days – 132 days
- Acceptance to online
- median 148 days (24 articles)
- Submission to online
- median 246 days
- Sample
- 24 articles with submission and acceptance dates (24 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Acceptance to publication
- 90 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access, Peer review, Plagiarism
- Open access Open Access
Published research is made freely available to readers in accordance with the journal's open access policy.
Source ↗Publisher website ·- Peer review Peer Review Policy
All peer review is single blind and submission is online via Open Journal Systems (OJS).
Source ↗Publisher website ·- Plagiarism Plagiarism Screening
Submitted manuscripts are screened using plagiarism detection tools before entering the peer-review process.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Zibeline International
- Country or region
- Malaysia
- Language
- English
- ISSN
- 2521-0807
- Electronic ISSN
- 2521-0424
- Official links
- Journal homepage ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Matrix Science Medica
How long does peer review take at Matrix Science Medica?
Based on the dates recorded on 24 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 52 days (interquartile range 33–132 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Matrix Science Medica open access, and what is the APC?
Matrix Science Medica is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .